The Bridge-Enhanced ACL Restoration (BEAR) Implant is the first medical technology to demonstrate with Level 1 clinical evidence that it enables the body to heal its own torn ACL. The BEAR Implant is indicated for a broad range of tear types and is implanted with an easy, bone-sparing technique shown step-by-step in this video.
For more information on the BEAR Implant, visit [ Ссылка ]
If you have any questions about the BEAR Implant, please comment below or contact us at [ Ссылка ].
Follow us on our social media channels:
Facebook – [ Ссылка ]
Twitter – [ Ссылка ]
LinkedIn – [ Ссылка ]
Instagram – [ Ссылка ]
#ACLsurgery #ACLtear #BEARimplant #AC:restoration
About The BEAR® Implant
The Bridge-Enhanced® ACL Restoration (BEAR®) Implant is a proprietary bio-engineered implant used to facilitate healing of the torn ACL. Unlike reconstruction, which is the current standard of care, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or the use of a donor tendon. The BEAR Implant acts as a bridge between the two ends of the torn ACL. The surgeon injects a small amount of the patient’s own blood into the implant and inserts it between the torn ends of the ACL in a minimally invasive procedure. The combination of the BEAR Implant and the patient’s blood enables the body to heal the torn ends of the ACL back together while maintaining the ACL’s original attachments to the femur and tibia. The BEAR Implant is absorbed by the body as the ACL heals.
The BEAR Implant was granted De Novo Approval from the U.S. Food and Drug Administration in December 2020. It is indicated for skeletally mature patients at least 14 years of age with a complete rupture of the ACL, as confirmed by MRI. Patients must have an ACL stump attached to the tibia to facilitate the restoration. Visit www.miachortho.com for complete product information, including Instructions for Use.
About Miach Orthopaedics, Inc.
Miach Orthopaedics, Inc. is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration. The company’s initial focus is the Bridge-Enhanced® ACL Restoration (BEAR®) Implant, which represents a paradigm shift in the treatment of ACL tears from reconstruction to restoration. The BEAR technology was pioneered by Martha Murray, M.D., founder of Miach Orthopaedics, at the Boston Children’s Hospital Department of Orthopaedic Surgery, with initial research funding provided by the NFL Players Association, Boston Children’s Hospital and the National Institutes of Health.
©2023 Miach Orthopaedics. All rights reserved.
ML-1118 Rev A 7/2022
